Correspondence 0001493152-24-028057 from Aeterna Zentaris Inc. (CSCI) (CIK 0001113423) (CSCIF)
Aeterna Zentaris Inc. (CSCI) (CIK 0001113423)
Date: July 16, 2024 · CIK: 0001113423 · Accession: 0001493152-24-028057
AI Filing Summary & Sentiment
File numbers found in text: 001-38064
Referenced dates: July 5, 2024
Show Raw Text
CORRESP
1
filename1.htm
Norton Rose Fulbright US LLP
1301 Avenue of the Americas
New York, NY 10019-6022 United States
Direct line +1 212-318-3151
Scott.Saks@nortonrosefulbright.com
Tel +1 212 318 3000
Fax +1 212 408 5100
nortonrosefulbright.com
July
16, 2024
FILED
VIA EDGAR
United
States Securities and Exchange Commission
Division
of Corporation Finance
Office
of Life Sciences
100
F Street, N.E.
Washington,
D.C. 20549
Attention:
Tara Harkins
Eric Atallah
Re: Aeterna
Zentaris Inc.
Form
20-F for Fiscal Year Ended December 31, 2023
File
No. 001-38064
Ladies
and Gentlemen:
On
behalf of Aeterna Zentaris Inc. (the “Company”), we are responding to the comment of the staff (the “Staff”)
of the U.S. Securities and Exchange Commission (the “Commission”) conveyed in the Staff’s Comment Letter, dated
July 5, 2024 (the “Comment Letter”), with respect to the Company’s Annual Report on Form 20-F for Fiscal Year
Ended December 31, 2023 (the “Annual Report”) filed with the Commission by the Company via EDGAR on March 27, 2024.
In connection with this response letter to the Comment Letter (the “Response Letter”), the Company has filed with
the Commission via EDGAR Amendment No. 1 to the Annual Report on Form 20-F/A (the “Amendment”), which has been revised
to reflect the Company’s responses to the Staff comment.
For
ease of review, we have set forth the Staff’s comment below in bold italics type followed by the Company’s response thereto.
Form
20-F for Fiscal Year Ended December 31, 2023
Exhibits
1. We
note that your officers’ Section 906 certifications furnished in Exhibits 13.1 and
13.2 pursuant to Rule 13a-14(b) of the Exchange Act refer to the year ended December 31,
2021 rather than for the year ended December 31, 2023. Please file a full amendment to your
Form 20-F which includes corrected and currently dated Section 906 certifications.
Response:
The Company respectfully acknowledges and has complied with the Staff’s comment by filing the full Amendment which includes corrected
and currently dated Section 906 certifications. See Exhibits 13.1 and 13.2 furnished with the Amendment. The Company has also included
new Section 302 Certifications and accountant consents as required by the rules and regulations of the Commission. See Exhibits 12.1,
12.2, 15.1 and 15.2 filed with the Amendment.
*
* *
United States Securities and Exchange Commission
July
16, 2024
Page 2
We
hope that the foregoing response and corresponding revisions to Exhibits 13.1 and 13.2 furnished with the full Amendment are responsive
to the Staff’s comments. Please do not hesitate to contact the undersigned, Scott R. Saks, of Norton Rose Fulbright US LLP, counsel
to the Company, at (212) 318-3151 or at scott.saks@nortonrosefulbright.com, or my colleague, Juan Felipe Velasquez, at (713) 651-5637
or at juan.felipe.velasquez@nortonrosefulbright.com, with any questions or comments.
Very Truly Yours
/s/ Scott
R. Saks
Scott R. Saks
cc:
Giuliano
La Fratta (Aeterna Zentaris Inc.)
Juan
Felipe Velasquez (Norton Rose Fulbright US LLP)
Norton
Rose Fulbright US LLP is a limited liability partnership registered under the laws of Texas.
Norton
Rose Fulbright US LLP, Norton Rose Fulbright LLP, Norton Rose Fulbright Australia, Norton Rose Fulbright Canada LLP and Norton Rose Fulbright
South Africa Inc are separate legal entities and all of them are members of Norton Rose Fulbright Verein, a Swiss verein. Norton Rose
Fulbright Verein helps coordinate the activities of the members but does not itself provide legal services to clients. Details of each
entity, with certain regulatory information, are available at nortonrosefulbright.com.